ФИБРИЛЛЯЦИЯ ПРЕДСЕРДИЙ ПОСЛЕ КАРДИОХИРУРГИЧЕСКИХ ОПЕРАЦИЙ: ПАТОФИЗИОЛОГИЯ И МЕТОДЫ ПРОФИЛАКТИКИ
https://doi.org/10.21292/2078-5658-2017-14-1-58-66
Аннотация
Фибрилляция предсердий является одним из наиболее частых осложнений, встречающихся после кардиохирургических вмешательств. Послеоперационная фибрилляция предсердий достоверно увеличивает риск развития летального исхода и ассоциированных осложнений. Патогенез развития данного заболевания зачастую обусловлен сочетанием нескольких провоцирующих факторов. В ходе поиска эффективной лекарственной терапии или других хирургических методов для профилактики послеоперационной фибрилляции предсердий проведено большое количество исследований среди пациентов кардиохирургического профиля. В настоящее время ни одна из предложенных схем профилактической терапии не гарантирует надежной защиты пациента от развития послеоперационной фибрилляции предсердий и ассоциированных осложнений. Поэтому весьма актуальным представляется проведение новых исследований, направленных на детальное изучение патофизиологии данного заболевания, и разработки эффективных способов профилактики и лечения.
Ключевые слова
Об авторах
В. В. ЛомиворотовРоссия
доктор медицинских наук, профессор, заместитель директора по научной работе, руководитель центра анестезиологии и реаниматологии
С. М. Ефремов
Россия
доктор медицинских наук, врач анестезиолог-реаниматолог
Е. А. Покушалов
Россия
доктор медицинских наук, профессор, заместитель директора по научно-экспериментальной работе, руководитель центра интервенционной кардиологии
В. А. Бобошко
Россия
кандидат медицинских наук, врач анестезиолог-реаниматолог
Список литературы
1. Алексин А. А. Послеоперационная фибрилляция предсердий при хирургических вмешательствах на легких // Вестн. анестезиол. и реаниматол. − 2014. − № 2. − С. 71−78.
2. Чернявский А. М., Пак И. А., Карева Ю. Е. Эффективность различных способов аблации длительно персистирующей фибрилляции предсердий во время операции коронарного шунтирования // Патология кровообр. и кардиохирургия. − 2015. − Т. 19, № 4. − С. 54–60.
3. Abacilar A. F., Dogan O. F. Levosimendan use decreases atrial fibrillation in patients after coronary artery bypass grafting: a pilot study // Heart Surg. Forum. − 2013. – Vol. 16. − Р. E287−Е294.
4. Acikel S., Bozbas H., Gultekin B. et al. Comparison of the efficacy of metoprolol and carvedilol for preventing atrial fibrillation after coronary bypass surgery // Int. J. Cardiol. − 2008. – Vol. 126. – P. 108−113.
5. Adams D. C., Heyer E. J., Simon A. E. et al. Incidence of atrial fibrillation after mild or moderate hypothermic cardiopulmonary bypass // Crit. Care Med. – 2000. – Vol. 28. – P. 309−311.
6. Alameddine A. K., Visintainer P., Alimov V. K. et al. Blood transfusion and the risk of atrial fibrillation after cardiac surgery // J. Card. Surg. − 2014. – Vol. 29. – P. 593−599.
7. Alghamdi A. A., Al-Radi O. O., Latter D. A. Intravenous magnesium for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and meta-analysis // J. Card. Surg. − 2005. – Vol. 20. – P. 293−299.
8. Anselmi A., Possati G., Gaudino M. Postoperative inflammatory reaction and atrial fibrillation: simple correlation or causation? // Ann. Thorac. Surg. − 2009. – Vol. 88. – P. 326–333.
9. Auer J., Weber T., Berent R. et al. Postoperative atrial fibrillation independently predicts prolongation of hospital stay after cardiac surgery // J. Cardiovasc. Surg. (Torino). − 2005. – Vol. 46. – P. 583−588.
10. Bagshaw S. M., Galbraith P. D., Mitchell L. B. et al. Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis // Ann. Thorac. Surg. − 2006. – Vol. 82. – P. 1927−1937.
11. Bakhtiary F., Therapidis P., Dzemali P. et al. Impact of high thoracic epidural anesthesia on incidence of perioperative atrial fibrillation in off-pump coronary bypass grafting: a prospective randomized study // J. Thorac. Cardiovasc. Surg. − 2007. – Vol. 134. – P. 460−464.
12. Beaulieu Y., Denault A. Y., Couture P. et al. Perioperative intravenous amiodarone does not reduce the burden of atrial fibrillation in patients undergoing cardiac valvular surgery // Anesthesiology. − 2010. – Vol. 112. – P. 128−137.
13. Blessberger H., Kammler J., Domanovits H. et al. Perioperative beta-blockers for preventing surgery-related mortality and morbidity // Cochrane Database Syst Rev. − 2014. – Vol. 18, № 9. − CD004476.
14. Bothe W., Olschewski M., Beyersdorf F. et al. Glucose-insulin-potassium in cardiac surgery: a meta-analysis // Ann. Thorac. Surg. − 2004. – Vol. 78. – P. 1650−1657.
15. Burgess D. C., Kilborn M. J., Keech A. C. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: A meta-analysis // Eur. Heart J. − 2006. – Vol. 27. – P. 2846−2857.
16. Calò L., Bianconi L., Colivicchi F. et al. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial // J. Am. Coll. Cardiol. − 2005. – Vol. 45. – P. 1723−1728.
17. Chello M., Patti G., Candura D. et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery // Crit. Care Med. − 2006. – Vol. 34. – P. 660−667.
18. Chen P. S., Chen L. S., Fishbein M. C. et al. Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy // Circ. Res. − 2014. – Vol. 114. – P. 1500−1515.
19. Chrysostomou C., Sanchez-de-Toledo J., Wearden P. et al. Perioperative use of dexmedetomidine is associated with decreased incidence of ventricular and supraventricular tachyarrhythmias after congenital cardiac operations // Ann. Thorac. Surg. − 2011. – Vol. 92. – P. 964−972.
20. Connolly S. J., Cybulsky I., Lamy A. et al. Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: The β-Blocker Length Of Stay (BLOS) study // Am. Heart J. − 2003. – Vol. 145. – P. 226−232.
21. Dieleman J. M., Nierich A. P., Rosseel P. M. et al. Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial // JAMA. − 2012. – Vol. 308. – P. 1761−1767.
22. Echahidi N., Pibarot P., O'Hara G. et al. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery // J. Am. Coll. Cardiol. − 2008. – Vol. 51. – P. 793−801.
23. Ehrlich J. R., Cha T. J., Zhang L. et al. Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties // J. Physiol. − 2003. – Vol. 551. – P. 801−813.
24. Gillespie E. L., White C. M., Kluger J. et al. Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery // Pharmacotherapy. − 2006. – Vol. 26. – P. 499−504.
25. Halonen J., Halonen P., Järvinen O. et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled study // JAMA 2007. – Vol. 297. – P. 1562−1567.
26. Hemmerling T. M., Minardi C., Zaouter C. et al. Sevoflurane causes less arrhythmias than desflurane after off-pump coronary artery bypass grafting: a pilot study // Ann. Card Anaesth. − 2010. – Vol. 13. – P. 116−122.
27. Katritsis D. G., Pokushalov E. A., Romanov A. et al. Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: a randomized clinical trial // J. Am. Coll. Cardiol. − 2013. – Vol. 62. – P. 2318−2325.
28. Kerin N. Z., Jacob S. The efficacy of sotalol in preventing postoperative atrial fibrillation: a meta-analysis // Am. J. Med. − 2011. – Vol. 124. – P. 875.e1–875.e9.
29. Kim Y. M., Kattach H., Ratnatunga C. et al. Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery // J. Am. Coll. Cardiol. − 2008. – Vol. 51. – P. 68–74.
30. Klemperer J. D., Klein I. L., Ojamaa K. et al. Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations // Ann. Thoracic Surgery. − 1996. – Vol. 61. – P. 1323−1329.
31. Klinger R. Y., Thunberg C. A., White W. D. Intraoperative magnesium administration does not reduce postoperative atrial fibrillation after cardiac surgery // Anesth Analg. − 2015. – Vol. 121, № 4. – P. 861−867.
32. Kolh P., Windecker S., Alfonso F. et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) // Eur. J. Cardiothorac Surg. − 2014. – Vol. 46. – P. 517−592.
33. Kromann N., Green A. Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950−1974 // Acta Med. Scand. − 1980. – Vol. 208. – P. 401−406.
34. Maesen B., Nijs J., Maessen J. et al. Post-operative atrial fibrillation: a maze of mechanisms // Europace. − 2012. – Vol. 14. – P. 159–174.
35. Maniar P. B., Balcetyte-Harris N., Tamis J. E. et al. Intravenous versus oral beta-blockers for prevention of post-CABG atrial fibrillation in high-risk patients identified by signal-averaged ECG: lessons of a pilot study // Card. Electrophysiol. Rev. − 2003. Vol. 7. – P. 1158−1161.
36. Mitchell L. B., Exner D. V., Wyse D. G. et al. Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair: PAPABEAR: a randomized controlled trial // JAMA. − 2005. − Vol. 294. – P. 3093−3100.
37. Mitchell L. B. Incidence, timing and outcome of atrial tachyarrhythmias after cardiac surgery, In Steinberg JS (ed): Atrial fibrillation after cardiac surgery. Norwell, MA: Kluwer Academic Publishers. − 2000. − P. 37−50.
38. Mozaffarian D., Marchioli R., Macchia A. et al. Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for prevention of post-operative atrial fibrillation (OPERA) randomized trial // JAMA. − 2012. – Vol. 308. – P. 2001−2011.
39. Nasso G., Costantini C., Petralia A. et al. A new extracorporeal vacuum-assisted device to optimize cardiopulmonary bypass. Comparison with the conventional system // Interact. Cardiovasc. Thorac. Surg. − 2011. – Vol. 12. – P. 591−595.
40. Patti G., Chello M., Candura D. et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study // Circulation. − 2006. – Vol. 114. – P. 1455−1461.
41. Pokushalov E., Romanov A., Corbucci G. et al. Benefit of ablation of first diagnosed paroxysmal atrial fibrillation during coronary artery bypass grafting: a pilot study // Eur. J. Cardiothorac. Surg. − 2012. – Vol. 41. – P. 556−560.
42. Pokushalov E., Romanov A., Artyomenko S. Left atrial ablation at the anatomic areas of ganglionated plexi for paroxysmal atrial fibrillation // Pacing and Clinical Electrophysiology. − 2010. − Vol. 33. − P. 1231−1238.
43. Pokyshalov E. A., Kozlov B., Romanov A. et al. Botulinum toxin injection in epicardial fat pads can prevent recurrences of atrial fibrillation after cardiac surgery: results of a randomized pilot study // J. Am. Coll. Cardiol. − 2014. – Vol. 64. – P. 628−629.
44. Rostagno C., Blanzola C., Pinelli F. et al. Atrial fibrillation after isolated coronary surgery. Incidence, long term effects and relation with operative technique // Heart Lung Vessel. − 2014. – Vol. 6. – P. 171−179.
45. Sanjuán R., Blasco M., Carbonell N. et al. Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery // Ann. Thorac. Surg. − 2004. – Vol. 77. – P. 838−843.
46. Steinberg J. S. Postoperative atrial fibrillation: a billion-dollar problem // J. Am. Coll. Cardiol. − 2004. – Vol. 43. – P. 1001−1003.
47. Wright D. G., Lefer D. J. Statin mediated protection of the ischemic myocardium // Vasc. Pharmacol. − 2005. − Vol. 42. – P. 265−270.
48. Yasunari K., Maeda K., Nakamura M. et al. Effects of carvedilol on oxidative stress in polymorphonuclear and mononuclear cells in patients with essential hypertension // Am. J. Med. − 2004. – Vol. 116. – P. 460−465.
49. Zaman A. G., Alamgir F., Richens T. et al. The role of signal averaged P wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery // Heart. − 1997. – Vol. 77. – P. 527−531.
50. Zhang B., Zhen Y., Tao A. et al. Polyunsaturated fatty acids for the prevention of atrial fibrillation after cardiac surgery: an updated meta-analysis of randomized controlled trials // J. Cardiol. − 2014. – Vol. 63. – P. 53−59.
Рецензия
Для цитирования:
Ломиворотов В.В., Ефремов С.М., Покушалов Е.А., Бобошко В.А. ФИБРИЛЛЯЦИЯ ПРЕДСЕРДИЙ ПОСЛЕ КАРДИОХИРУРГИЧЕСКИХ ОПЕРАЦИЙ: ПАТОФИЗИОЛОГИЯ И МЕТОДЫ ПРОФИЛАКТИКИ. Вестник анестезиологии и реаниматологии. 2017;14(1):58-66. https://doi.org/10.21292/2078-5658-2017-14-1-58-66
For citation:
Lomivorotov V.V., Efremov S.M., Pokushalov E.A., Boboshko V.A. ATRIAL FIBRILLATION AFTER CARDIAC SURGERY: PATHOPHYSIOLOGY AND PREVENTION TECHNIQUES. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2017;14(1):58-66. (In Russ.) https://doi.org/10.21292/2078-5658-2017-14-1-58-66